287 related articles for article (PubMed ID: 25795792)
1. Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.
Akgoc Z; Sena-Esteves M; Martin DR; Han X; d'Azzo A; Seyfried TN
J Lipid Res; 2015 May; 56(5):1006-13. PubMed ID: 25795792
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.
Sandhoff K; Harzer K
J Neurosci; 2013 Jun; 33(25):10195-208. PubMed ID: 23785136
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
Kobayashi T; Goto I; Okada S; Orii T; Ohno K; Nakano T
J Neurochem; 1992 Oct; 59(4):1452-8. PubMed ID: 1402895
[TBL] [Abstract][Full Text] [Related]
4. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
5. Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.
Anheuser S; Breiden B; Sandhoff K
J Lipid Res; 2019 Jun; 60(6):1099-1111. PubMed ID: 30988135
[TBL] [Abstract][Full Text] [Related]
6. Canine GM2-Gangliosidosis Sandhoff Disease Associated with a 3-Base Pair Deletion in the HEXB Gene.
Wang P; Henthorn PS; Galban E; Lin G; Takedai T; Casal M
J Vet Intern Med; 2018 Jan; 32(1):340-347. PubMed ID: 29106755
[TBL] [Abstract][Full Text] [Related]
7. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease.
Baek RC; Martin DR; Cox NR; Seyfried TN
Lipids; 2009 Mar; 44(3):197-205. PubMed ID: 19034545
[TBL] [Abstract][Full Text] [Related]
9. Bis(monoacylglycero)phosphate as a Macrophage Enriched Phospholipid.
Akgoc Z; Iosim S; Seyfried TN
Lipids; 2015 Sep; 50(9):907-12. PubMed ID: 26205346
[TBL] [Abstract][Full Text] [Related]
10. The Emerging and Diverse Roles of Bis(monoacylglycero) Phosphate Lipids in Cellular Physiology and Disease.
Showalter MR; Berg AL; Nagourney A; Heil H; Carraway KL; Fiehn O
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137979
[TBL] [Abstract][Full Text] [Related]
11. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
[TBL] [Abstract][Full Text] [Related]
12. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
Kohyama M; Yabuki A; Ochiai K; Nakamoto Y; Uchida K; Hasegawa D; Takahashi K; Kawaguchi H; Tsuboi M; Yamato O
BMC Vet Res; 2016 Mar; 12():67. PubMed ID: 27036194
[TBL] [Abstract][Full Text] [Related]
13. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
14. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.
Jabs S; Quitsch A; Käkelä R; Koch B; Tyynelä J; Brade H; Glatzel M; Walkley S; Saftig P; Vanier MT; Braulke T
J Neurochem; 2008 Aug; 106(3):1415-25. PubMed ID: 18498441
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical, morphological, and neurophysiological abnormalities in retinas of Sandhoff and GM1 gangliosidosis mice.
Denny CA; Alroy J; Pawlyk BS; Sandberg MA; d'Azzo A; Seyfried TN
J Neurochem; 2007 Jun; 101(5):1294-302. PubMed ID: 17442056
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases.
Hasegawa D; Tamura S; Nakamoto Y; Matsuki N; Takahashi K; Fujita M; Uchida K; Yamato O
PLoS One; 2013; 8(12):e83455. PubMed ID: 24386203
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
Utz JR; Crutcher T; Schneider J; Sorgen P; Whitley CB
Mol Genet Metab; 2015 Feb; 114(2):274-80. PubMed ID: 25557439
[TBL] [Abstract][Full Text] [Related]
20. Altered phosphoinositide-specific phospholipase C and adenylyl cyclase in brain cortical membranes of cats with GM1 and GM2 gangliosidosis.
Claro E; Wallace MA; Fain JN; Nair BG; Patel TB; Shanker G; Baker HJ
Brain Res Mol Brain Res; 1991 Oct; 11(3-4):265-71. PubMed ID: 1661824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
